Gastric cancer associated with overexpression of parathyroid hormone-related peptide (PTHrP) and PTH/PTHrP receptor in relation to tumor progression

Journal of Gastroenterology

Volumn 32, Issue 3, 1997, Pages 396-400

  Ito, Masahiro ^a   Nakashima, Masahiro ^a   Alipov, Gabit K ^a   Matsuzaki, Sumihiro ^a   Ohtsuru, Akira ^a   Yano, Hiroyuki ^a   Yamashtta, Shunichi ^a   Sekine, Ichiro ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Gastric cancer; Progression; PTH PTHrP receptor; PTHrP

Indexed keywords

CALCIUM ION; MESSENGER RNA; PARATHYROID HORMONE RECEPTOR; PARATHYROID HORMONE RELATED PROTEIN;

ADULT; ARTICLE; AUTOPSY; BONE METASTASIS; CALCIUM BLOOD LEVEL; CANCER CELL; CASE REPORT; CELL PROLIFERATION; HUMAN; HUMAN CELL; HYPERCALCEMIA; IMMUNOHISTOLOGY; LYMPH NODE METASTASIS; MALE; METASTASIS; PERITONEUM METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STOMACH CANCER; TUMOR DIFFERENTIATION; TUMOR GROWTH;

EID: 0030957687     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02934499     Document Type: Article

References (27)

1. Moseley JM, Kubota MM, Diffenback-Jagger H, et al. Parathyroid hormone-related protein purified from a human lung cancer cell line. Proc Natl Acad Sci USA 1987;84:5048-5052.
2. Strewler GJ, Stern PH, Jacobs JW, et al. Parathyroid hormone-like protein from human renal cell carcinoma cells. J Clin Invest 1987;80:1803-1807.
3. Margin M, Ikeda K, Dreyer BE, et al. Isolation and characterization of the human parathyroid hormone-like peptide gene. Proc Nail Acad Sci USA 1989;86:2408-2452.
4. Urena P, Kong XF, Abou-Samra A, et al. Parathyroid hormone (PTH)/PTH-related peptide receptor messenger ribonucleic acids are widely distributed in rat tissues. Endocrinology 1993;133:617-623.
5. Burton PB, Knight DE. Parathyroid hormone-related peptide can regulate the growth of human lung cancer cells, and may form part of an autocrine TFG-alpha loop. FEBS Lett 1992;305:228-232.
6. Akino K, Ohtsuru A, Yano H, et al. Antisense inhibition of parathyroid hormone-related peptide gene expression reduces malignant rat pituitary tumor progression and metastases. Cancer Res 1996;56:77-86.
7. Ito M, Enomoto H, Usa T, et al. Expression of parathyroid hormone-related peptide in human pituitary tumors. J Clin Pathol 1993;48:682-683.
8. Iwamura M, Sant'Agnese PA, Wu G, et al. Immunohistochemical localization of parathyroid hormone-related protein in human prostate cancer. Cancer Res 1993;53:1724-1726.
9. Sidler B, Alpert L, Henderson JE, et al. Overexpression of parathyroid hormone-related peptide following gene amplification in colonie carcinoma. In: Abstract of 76th Annual Meeting of Endocrine Society, Bethesda, Endocrine Society, 1994:330.
10. Yamamura-Idei Y, Kitasawa S, Kitasawa R, et al. Parathyroid hormone-related protein in gastric cancers with heterotopic ossification. Cancer 1993;72:1849-1852.
11. Roskams T, Willems M, Campos RV, et al. Parathyroid hormone-related peptide expression in primary and metastic liver tumours. Histopathology 1993;23:519-525.
12. Abdeen O, Pandol SJ, Burton DW, et al. Parathyroid hormone-related protein expression in human gastric adenocarcinoma. Am J Gastroenterol 1995;90:1864-1867.
13. Burton PB, Moniz C, Knight DE. Parathyroid hormone-related peptide can function as an autocrine growth factor in human renal cell carcinoma. Biochem Biophys Res Commun 1990;167:1134-1138.
14. Liu B, Goltzman D, Rabbani SA. Processing of pro-PTHrP by the prohormone convertase, furin: Effect on biological activity. Am J Physiol 1995;268:E832-E838.
15. Vargas SJ, Gillespie MT, Powell GJ, et al. Localization of parathyroid hormone-related protein mRNA expression in breat cancer and metastatic lesions by in situ hybridization. J Bone Mineral Res 1992;7:971-979.
16. Nakashima M, Ohtsuru A, Luo WT, et al. Expression of parathyroid hormone-related peptide in human thyroid tumours. J Pathol 1995;175:227-236.
17. Luparello C, Burtis WJ, Raue F, et al. Parathyroid hormone-related peptide and 8701-BC breast cancer cell growth and invasion in vitro: Evidence for growth-inhibiting and invasion-promoting effects. Mol Cell Endocrinol 1995;111:225-232.
18. Rodan SB, Wesolowski G, Ianacone J, et al. Production of parathyroid hormone-like peptide in a human osteosarcoma cell line: Stimulation by phorbol esters and epidermal growth factor. J Endocrinol 1989;122:219-27.
19. Kiriyama T, Gillespie MT, Glatz JA, et al. Transforming growth factor β stimulation of parathyroid hormone-related peptide: A paracrine regulator? Mol Cell Endocrinol 1993;92:55-62.
20. Kihana T, Tsuda H, Teshima S, et al. High incidence of p53 gene mutation in human ovarian cancer and its association with nuclear accumulation of p53 protein and tumor DNA aneuploidy. Jpn J Cancer Res 1992;83:987-994.
21. Kihana T, Tsuda H, Hirota T, et al. Point mutation of c-Ki-ras oncogene in gastric adenoma and adenocarcinoma with tubular differentiation. Jpn J Cancer Res 1991;82:308-314.
22. Yonemura Y, Takamura H, Ninomiya I, et al. Interrelationship between transforming growth factor-alpha and epidermal growth factor receptor in advanced gastric cancer. Oncology 1992;49:157-161.
23. Nakayama H, Yasui W, Yokozaki H, et al. Reduced expression of nm23 is associated with metastasis of human gastric carcinomas. Jpn J Cancer Res 1993;84:184-190.
24. Sugimura T, Yoshida T, Sakamoto H, et al. Molecular biology of the hst-1 gene. Ciba Foundation Symposium 1990;150:79-89.
25. Kameda T, Yasui W, Yoshida K, et al. Expression of ERBB2 in human gastric carcinomas: Relationship between p185 ERBB2 expression and the gene amplification. Cancer Res 1990;50:8002-8009.
26. Hattori Y, Odagiri H, Nakatani H, et al. K-sam, an amplified gene in stomach cancer, is a member of the heparin-binding growth factor receptor genes. Proc Natl Acad Sci USA 1990;87:5983-5987.
27. Kuniyasu H, Yasui W, Kitadai Y, et al. Frequent amplification of the c-met gene in scirrhous type stomach cancer. Biochem Biophys Res Commun 1992;189:227-232.